30 closest matches · ranked by relevance
AMD
Primary: Change in Dark Adaptation Rod Intercept Time (RIT) From Baseline in the Study Eye at the Treatment Completion Visit (Month 2 for Cohort 1 and Month 1 for Cohort 2)…
Reticular Pseudodrusen (RPD) · Age-Related Macular Degeneration
Primary: Change in Dark Adaptation Rod Intercept Time (RIT) From Baseline in the Study Eye at the Treatment Completion Visit (Month 2 for Cohort 1 and Month 1 for Cohort 2)…
Vitamin A Deficiency · Maternal Mortality · Infant Mortality
Primary: All-cause, Pregnancy-related Mortality — 41; 47; 50 Participants — p=0.05
Relapsing Remitting Multiple Sclerosis
Primary: Difference Serum Levels of High-sensitive C-reactive Protein (Hs-CRP), Before and After of Supplementation — 1.2; -0.6 mg/L — p=<0.01
Anemia
Primary: Haemoglobin Level — 88.3; 89.2; 88.4; 89.6 g/L — p=<0.05
Vitamin D Deficiency · Pregnancy
Primary: 25-hydroxyvitamin D at Visit 7 — 36.7; 39.8 ng/mL
Rheumatoid Arthritis · Vitamin D Deficiency
Primary: Disease Activity Score (DAS) 28 — 3.4; 2.8; 3.5; 3.1 composite score
Vitamin D Deficiency
Primary: Level of Serum 25 OHD Level Pre-treatment and Post Treatment — 12.03; 10.36; 37.17; 10.51 ng/mL — p=0.9
Vitamin D Deficiency
Primary: Serum-vitamin D — 19.7; 34.4; 38.7; 58.7 25(OH)D, nmol/L — p=0.001
Kidney Transplantation · Vitamin D Deficiency
Primary: Compare Efficacy and Safety of Two Vitamin D Supplements of These Doses in Normalizing Vitamin D Concentrations. — 8; 29 ng/ml
Vitamin D Deficiency · Gastrointestinal Diseases
Primary: # of Pts w/ Enhanced Vitamin D Status — 3; 3 Participants
Healthy
Primary: Serum 25-hydroxyvitamin D — 26.7; 22.4 ng/mL — p=0.003
Asthma
Primary: Number of Participants With Sufficient Vitamin D Levels (≥30 ng/ml) After 8 Weeks of Supplementation — 8; 6; 4 participants
Respiratory Distress Syndrome
Primary: Respiratory Distress Syndrome — 52; 3 participants
Atopic Dermatitis · Psoriasis
Primary: Change From Baseline on Day 21 in Relative Abundance of CAMP mRNA in Lesional and Non-Lesional Skin for Atopic Dermatitis (AD) Participants Who Received Oral Vitamin D3…
Healthy Participants
Primary: Percentage of Participants With Positive Responses in Virus-specific Antibody in Sera — 80; 75; 100; 100 percentage of participants
HIV Infections · AIDS
Primary: Safety — 0; 0 participants
Asthma
Primary: Change From Baseline in Serum 25OHD — 4.3; 9.6 nmol/L
Healthy Subjects · Vitamin D Deficiency
Primary: hCAP18 Levels — 762; 639 ng/ml
Actinic Keratosis
Primary: Changes From Baseline in Actinic Keratosis - Lesion Base Count. — 1.15; 2.65; 1.15; 2.60 lesions — p=<0.001
Vitamin D Deficiency · Short Bowel Syndrome
Primary: 25 Hydroxy Vitamin D Levels — 26; 14; 19; 17 ng/mL
Male Infertility, Azoospermia
Primary: Total Motile Sperm — 8; 1 Participants
Sickle Cell Disease · Vitamin D Deficiency · Acute Chest Syndrome
Primary: Mean Annual Rate of Respiratory Events — 3.91; 4.34; 3.34; 4.28 events per year
Frail Elderly · Vitamin d Deficiency
Primary: Change in Short Physical Performance Battery Test Score — 7.3; 7.0 units on a scale
Obesity · Endothelial Dysfunction · Vitamin D Deficiency
Primary: Flow Mediated Dilatation (FMD) — 9.5; 10.4 percentage increase in BAD — p=0.59
Rheumatoid Arthritis · Hypovitaminosis D
Primary: Parathyroid Hormone Level — 19; 20 pg/mL
Vitamin D Deficiency · Coronary Artery Disease · Endothelial Dysfunction
Primary: Endothelial Function — 0.13; -0.04 reactive hypermia index
Sickle Cell Disease · Anemia, Sickle Cell · Anemia, Hemolytic, Congenital
Primary: Annual Rate of Respiratory Events — 3.3; 3.3; 3.4; 3.2 Respiratory events per year
Retinitis Pigmentosa · X-linked Genetic Diseases
Primary: Rate of LOSS of 31 Hertz Cone Electroretinographic Function — 0.028; 0.022 log microvolts/year — p=0.30
Asthma
Primary: Asthma or Recurrent Wheeze in First 3 Years of Life — 98; 120; 307; 281 Participants